Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group gerresheimer.com/en/company/…
#pharmamanufacturing #drugdelivery #drugdevices #biotech
Gerresheimer builds new production capacities for glass syringes at Skopje site gerresheimer.com/en/company/…
Gerresheimer reports a solid start to the financial year 2024 and continues its profitable growth course.
gerresheimer.com/en/company/…
#FYresults #innovatingforabetterlife #gerresheimer #GLP1 #biologics #pharma #cosmetics #drugdelivery
We will publish our Q1 2024 results on April 11, 2024 at 7 am CEST on our website in the IR section here: gerresheimer.com/en/company/…
“In 2023, we achieved double-digit revenue and adjusted EBITDA growth. We expanded our organic adjusted EBITDA margin by 120 basis points 20.8%.”
Read our annual report: gerresheimer.com/fileadmin/u…
#FYresults #gerresheimer #pharma #cosmetics #drugdelivery
Gerresheimer decisively continued on its profitable growth course in the financial year 2023.
Read our Corporate News: gerresheimer.com/en/company/…
#FYresults #innovatingforabetterlife #gerresheimer #GLP1 #biologics #pharma #cosmetics #drugdelivery
Press release: Green electricity from wind for German production sites gerresheimer.com/en/company/…
#Sustainability #greenelectricity
Gerresheimer awarded EcoVadis Gold status again
As an innovative provider of systems and solutions and a global partner for the pharma, biotech, and cosmetic industries, we have once again been awarded Gold status by the ratings agency EcoVadis.
gerresheimer.com/en/company/…
The German financial magazine „Der Aktionär“ published an article about Gerresheimer in its issue No. 35/2023. The interview (in German, paywall) can also be found here: deraktionaer.de/artikel/phar…
#gerresheimer #pharma #bitotech #press
Gerresheimer continues dynamic growth in first half of 2023
Read our Corporate News
lnkd.in/erq7gJXu
#innovatingforabetterlife #gerresheimer #pharma
Gerresheimer has assumed responsibility for the industrialization of a dry powder inhaler for the treatment of respiratory ailments for Merxin (United Kingdom), a company that specializes in making inhaler devices.
gerresheimer.com/en/company/…
Annual General Meeting of Gerresheimer AG approves dividend of EUR 1.25 per share following a successful financial year – Gradual renewal of Supervisory Board initiated gerresheimer.com/en/company/…
Gerresheimer raises revenue guidance for 2022 to double-digit growth after strong first quarter gerresheimer.com/en/company/…
#gerresheimer #innovatingforabetterlife
Sustainable entrepreneurship and profitable growth are not mutually exclusive, but rather mutually dependent. We have driven the transformation of our Gerresheimer into a sustainable and innovative growth company.
gerresheimer.com/en/company/…
#innovatingforabetterlife #sustainability
As a supplier of critical healthcare infrastructure, we are an essential and mission-critical partner for everyone needing these products – in particular Pharma and biotech companies.
Our annual report 2021: gerresheimer.com/en/company/…
Our fiscal year 2021 at a glance
Our video summarizes the key results and statements on fiscal 2021!
Click here for our annual report: gerresheimer.com/en/company/…
#innovatingforabetterlife #gerresheimer# #pharma #cosmetics #biologicals
Gerresheimer accelerates growth and raises mid term guidance gerresheimer.com/en/company/…
#innovatingforabetterlife #healthcare #cosmetics #biologics
The leading supplier of injection vials Gerresheimer expands production in Wertheim
gerresheimer.com/en/company/…
#innovatingforabetterlife #pharma #germany #production
Around 10.000 employees are working all around the globe, in production plants in 14 countries. One Gerresheimer team. Welcome to Gerresheimer. Our passion: Innovating for a better life.
gerresheimer.com/en/careers #innovatingforabetterlife #Career















